Drug Discovery & DevelopmentHalozyme shares jump after FDA lifts hold on trialReuters(Reuters) – Shares of Halozyme Therapeutics Inc jumped about 11 percent a day after the U.S. Food and Drug Administration lifted a hold on a trial testing an advanced version of the company’s flagship drug delivery technology. The company said on …Halozyme soars after the FDA backs off of its cancer studyFierceBiotechHalozyme Therapeutics Inc. (HALO) Is Sharply Higher On FDA NewsRTT NewsCurrent Market Movers: Halozyme Therapeutics, Inc. (NASDAQ:HALO), Abraxas …Markets EmergingMarket News Call -TheStreet.com -Benzingaall 28 news articles …Read Full Story
Halozyme shares jump after FDA lifts hold on trial - Reuters
Real Estate of Cebu
